"Robb Well Being" contained the declared substances methyl salicylate, menthol, camphor and eucalyptol and is therefore to be classified as an illegal medicinal product.

"Moove Pain Relief Specialist" contained the declared substances methyl salicylate, menthol and eucalyptol and is therefore to be classified as an illegal medicinal product.

Regulation 1234/2008/EC was amended by Delegated Regulation (EU) 2024/1701 and will enter into force on 1 January 2025.

"Hoe Hin White Flower Olie" contained the declared active substances methyl salicylate, menthol, camphor and eucalyptol and is therefore to be classified as an illegal medicinal product.

"EXS Delay Spray" contained the undeclared active ingredient lidocaine and is therefore to be classified as an illegal medicinal product.

The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that, in addition to the regions already announced, confirmed human WNV infections have been recorded in Pogradec in Albania.

The Federal Office for Safety in Health Care (BASG) warns of a potential contamination of the non-sterile ultrasound gel “AquaUltra Clear” from the manufacturer Ultragel Medical Kft. According to the manufacturer, the affected batches can be identified by the LOT numbers 2024-04 to 2024-10.

The Federal Office for Safety in Health Care has been informed by the Danish authority that it has been informed by the Danish tissue bank European Sperm Bank (DK257572) that the sperm donor 8558/Edward has been diagnosed with type 2 diabetes (DM2). The donor/gametes have been permanently blocked.

The Federal Office for Safety in Health Care has been informed by the Danish authority that it has been informed by the Danish tissue bank European Sperm Bank (DK257572) that an offspring of the sperm donor 28203/INGO has been diagnosed with Joubert syndrome. The child shows a Dandy Walker malformation. The donor/gametes have been permanently blocked.

Up-to-date information from the 11.11.-14.11.2024 meeting on new approvals, extensions of indication, newly published EPAR's and recently started procedures.